China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy

Overview of attention for article published in Cancer Communications, June 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 79 Dimensions

Readers on

mendeley: 56 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,454 followers.

China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy. #lymphoma #lymsm https://t.co/VprtPuE1tD

22 Jun 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.